The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
Authors
Keywords
NAD, nicotinamide adenine dinucleotide, NR, mitochondria, parkinsonism, neurodegeneration, neuroprotective, treatment, experimental therapy, disease modifying
Journal
Cell Metabolism
Volume 34, Issue 3, Pages 396-407.e6
Publisher
Elsevier BV
Online
2022-03-02
DOI
10.1016/j.cmet.2022.02.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parkinson's disease
- (2021) Bastiaan R Bloem et al. LANCET
- Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain
- (2021) Lilah Toker et al. Molecular Neurodegeneration
- DNA damage and repair in Parkinson's disease: Recent advances and new opportunities
- (2020) Claudia P. Gonzalez‐Hunt et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Resistance training increases muscle NAD+ and NADH concentrations as well as NAMPT protein levels and global sirtuin activity in middle-aged, overweight, untrained individuals
- (2020) Donald A. Lamb et al. Aging-US
- NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
- (2020) Nady Braidy et al. EXPERIMENTAL GERONTOLOGY
- Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models
- (2020) Benjamin A. Harlan et al. EXPERIMENTAL NEUROLOGY
- Nicotinamide riboside protects noise-induced hearing loss by recovering the hair cell ribbon synapses
- (2020) Shuguang Han et al. NEUROSCIENCE LETTERS
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
- (2020) Brit Mollenhauer et al. MOVEMENT DISORDERS
- RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types
- (2019) Gianni Monaco et al. Cell Reports
- Dysfunction of Cellular Proteostasis in Parkinson’s Disease
- (2019) Šárka Lehtonen et al. Frontiers in Neuroscience
- Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
- (2019) Dietrich Conze et al. Scientific Reports
- Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
- (2019) Yasir S. Elhassan et al. Cell Reports
- Nicotinamide and NAFLD: Is There Nothing New Under the Sun?
- (2019) Maria Guarino et al. Metabolites
- NAD+ in Brain Aging and Neurodegenerative Disorders
- (2019) Sofie Lautrup et al. Cell Metabolism
- Systemic activation of Nrf2 pathway in Parkinson's disease
- (2019) Sara Petrillo et al. MOVEMENT DISORDERS
- A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects
- (2018) Ole L Dollerup et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Biomarkers for mitochondrial energy metabolism diseases
- (2018) Sara Boenzi et al. Essays in Biochemistry
- Network imaging biomarkers: insights and clinical applications in Parkinson's disease
- (2018) Katharina A Schindlbeck et al. LANCET NEUROLOGY
- Unveiling a hidden 31 P signal coresonating with extracellular inorganic phosphate by outer-volume-suppression and localized 31 P MRS in the human brain at 7T
- (2018) Jimin Ren et al. MAGNETIC RESONANCE IN MEDICINE
- Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
- (2018) Christopher R. Martens et al. Nature Communications
- The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson’s Disease
- (2018) David C. Schöndorf et al. Cell Reports
- Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer’s disease model mice
- (2018) Xian Xie et al. METABOLIC BRAIN DISEASE
- Gene therapy reduces Parkinson’s disease symptoms by reorganizing functional brain connectivity
- (2018) Martin Niethammer et al. Science Translational Medicine
- Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity
- (2017) Vincenzo Sorrentino et al. NATURE
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- Precision medicine for disease modification in Parkinson disease
- (2017) Alberto J. Espay et al. Nature Reviews Neurology
- OXSA: An open-source magnetic resonance spectroscopy analysis toolbox in MATLAB
- (2017) Lucian A. B. Purvis et al. PLoS One
- Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration
- (2016) Sarmistha Mukherjee et al. HEPATOLOGY
- Safety assessment of nicotinamide riboside, a form of vitamin B3
- (2016) DB Conze et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
- (2016) Jenni M. Lehtonen et al. NEUROLOGY
- Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
- (2016) Samuel A. J. Trammell et al. Nature Communications
- Acetyl Coenzyme A: A Central Metabolite and Second Messenger
- (2015) Federico Pietrocola et al. Cell Metabolism
- Regulation of Histone Acetylation by Autophagy in Parkinson Disease
- (2015) Goonho Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Quantification ofin vivo31P NMR brain spectra using LCModel
- (2015) Dinesh Kumar Deelchand et al. NMR IN BIOMEDICINE
- OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease
- (2015) Thomas E. Akie et al. PLoS One
- Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies
- (2015) Natália Pessoa Rocha et al. Biomed Research International
- Activation of SIRT3 by the NAD+ Precursor Nicotinamide Riboside Protects from Noise-Induced Hearing Loss
- (2014) Kevin D. Brown et al. Cell Metabolism
- Network modulation following sham surgery in Parkinson’s disease
- (2014) Ji Hyun Ko et al. JOURNAL OF CLINICAL INVESTIGATION
- Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain
- (2014) Jamie Near et al. MAGNETIC RESONANCE IN MEDICINE
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- Characterization of disease-related covariance topographies withSSMPCAtoolbox: Effects of spatial normalization and PET scanners
- (2013) Shichun Peng et al. HUMAN BRAIN MAPPING
- Metabolic network as a progression biomarker of premanifest Huntington’s disease
- (2013) Chris C. Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra
- (2013) Richard A.E. Edden et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Intracellular redox state revealed by in vivo31P MRS measurement of NAD+and NADH contents in brains
- (2013) Ming Lu et al. MAGNETIC RESONANCE IN MEDICINE
- Validation of parkinsonian disease-related metabolic brain patterns
- (2013) Laura K. Teune et al. MOVEMENT DISORDERS
- Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging
- (2013) Ping Wu et al. PARKINSONISM & RELATED DISORDERS
- Metabolic brain networks in translational neurology: Concepts and applications
- (2012) Martin Niethammer et al. ANNALS OF NEUROLOGY
- Improved Sequence Learning with Subthalamic Nucleus Deep Brain Stimulation: Evidence for Treatment-Specific Network Modulation
- (2012) H. Mure et al. JOURNAL OF NEUROSCIENCE
- Multivariate Data Analysis for Neuroimaging Data: Overview and Application to Alzheimer’s Disease
- (2010) Christian Habeck et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Gene function analysis in complex data sets using ErmineJ
- (2010) Jesse Gillis et al. Nature Protocols
- Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects
- (2010) Hideo Mure et al. NEUROIMAGE
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started